Repository

• Home
• Repository
• Publications

Publications

Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer Castet F, Fabregat-Franco C, Bridgewater J, Kim JW, Rimini M, La Casta A, Lamarca A, Kang M, Salani F, Castillo A, Lopes A, Hyung J, Rimassa L, Adeva J, López-Valbuena D, Basagaña-Farres M, Vaja S, Mak KM, Tian TV, Muñoz A; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD); Casadei-Gardini A; DURVABTC Group; Yoo C, Valle JW, Macarulla T J Hepatol. 2025 Nov;83(5):1102-1115. doi: 10.1016/j.jhep.2025.05.020 2025  Result from

Evolving Precision: Updates in Targeted Therapy for Cholangiocarcinoma Tesini G, Ibrahim H, Rimassa L, Braconi C Hepatology. 2025 Sep 22. doi: 10.1097/HEP.0000000000001541 2025  Result from   Funded by

Impact of antibiotic therapy in patients with cholangiocarcinoma treated with chemoimmunotherapy Vitiello F, Vivaldi C, Rizzato MD, Saborowski A, Antonuzzo L, Rossari F, Salani F, Kim JW, Rapposelli IG, Tamburini E, Rimini M, Prinzi FL, Satake T, Peeters F, Pressiani T, Lucchetti J, Abidoye O, Gallio C, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, Braconi C, Qaisar A, Pastorino A, Castet F, Yoo C, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Parisi A, Diana A, Couto N, Chan SL, Garajova I, Roque R, Ikeda M, Niger M, Tonini G, Himmelsbach V, Landriscina M, Masi G, Vogel A, Lonardi S, Fornaro L, Rimassa L, Casadei-Gardini A, Adeva J, Spinelli GP, Personeni N, Rodriguez MG, Leo S, Alvim CM, Farinea G, Genovesi V, De Rosa A, Lavacchi D, Camera S, Dekervel J, Balsano R, Kang M, Tesini G, Esposito L, Boccancino A, Ahcene Djaballah S, Bekaii-Saab T. Oncology. 2025 Aug 14:1-26. doi: 10.1159/000546856 2025  Result from

Leveraging Multimodal Foundation Models in Biliary Tract Cancer Research Singh Y, Andersen JB, Hathaway QA, Vera-Garcia DV, Keishing V, Venkatesh SK, Salehi S, Povero D, Wallace MB, Gores GJ, Wei Y, Horvat N, Erickson BJ, Quaia E Tomography. 2025 Aug 25;11(9):96. doi: 10.3390/tomography11090096 2025  Results from

NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts Amengual J, Gonzalez-Sanchez E, Yáñez-Bartolome M, Sererols-Viñas L, Ravichandra A, Guiton C, Fuste NP, Alay A, Hijazo-Pechero S, Martín-Mur B, Gut M, Esteve-Codina A, Cantos-Cortes A, Espinosa-Sotelo R, Ramos E, Serrano T, Calvo M, Laquente B, Ferrer J, Pons G, Mendez-Lucas A, Dooley S, Ilyas SI, Vallette M, Aoudjehane L, Lequoy M, Fouassier L, Coulouarn C, Affò S, Scheiter A, Calvisi DF, Tian TV, Fabregat I, Vaquero J. Signal Transduct Target Ther. 2025 Aug 18;10(1):257. doi: 10.1038/s41392-025-02347-z 2025  Result from   OA Funded by